About the Procedure
Latest Live Webcast from Brigham and Women’s Hospital Features Advanced Corrective Procedure for Cardiac Arrhythmia
Webcast to highlight specialized care for women with heart rhythm problems
Boston, MA – On Wednesday, June 14, 2006 at 4:30 p.m. ET, Brigham and Women’s Hospital (BWH) electrophysiologists will demonstrate a live catheter ablation for supraventricular tachycardia (SVT), a type of cardiac arrhythmia or heart rhythm problem that can be more common in women and can exhibit significant symptoms. Designed to educate physicians and patients about SVT and discuss the latest catheter ablation procedure, the webcast will also provide information about specialized care for women with cardiac arrhythmias from specialists at the BWH Women and Arrhythmias Program.
SVT symptoms can begin at any age and can have a major impact on quality-of-life. During an SVT episode, the heart can beat faster than 200 beats per minute – sometimes more than three times the average resting heart rate of 60 to 80 beats per minute – and, when severe, can result in lightheadedness and fainting. SVT and other arrhythmias can often be cured by catheter ablation, a minimally invasive procedure that involves the insertion of catheters (wires) into the heart. Using advanced imaging to guide the catheters to the arrhythmia source, electrophysiologists deliver radiofrequency electrical energy to selectively eliminate the heart cells that are causing the rhythm disturbance.
Usha B. Tedrow, MD, Director of the Women and Arrhythmias Program at BWH, will perform a live SVT ablation procedure, and Christine M. Albert, MD, MPH, Director of the Center for Arrhythmia Prevention at BWH, will narrate and respond to questions from viewers during the live webcast.
“We are pleased to offer this educational program and share our insights into management of SVT, as well as gender-specific care and considerations for patients with cardiac arrhythmias,” said Dr. Tedrow.
Brigham and Women's Hospital is a 747-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare System, an integrated health care delivery network. BWH is committed to excellence in patient care with expertise in virtually every specialty of medicine and surgery. The BWH medical preeminence dates back to 1832 and today that rich history in clinical care is coupled with its national leadership in quality improvement and patient safety initiatives, dedication to educating and training health care professionals, and strength in biomedical research. With $370M in funding and more than 500 research scientists, BWH is an acclaimed leader in clinical, basic and epidemiological investigation - including the landmark Nurses Health Study, Physicians Health Studies, and the Women's Health Initiative. For more information about BWH, please visit: www.brighamandwomens.org.